In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives

Head and Face Medicine

Volumn 5, Issue 1, 2009, Pages

  Reichert, Christoph ^a   Al Nawas, Bilal ^b   Smeets, Ralf ^c   Kasaj, Adrian ^b   Götz, Werner ^a   Klein, Marcus O ^b  

^a UNIVERSITY OF BONN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN; OXAZINE DERIVATIVE; RESAZURIN; XANTHENE DERIVATIVE;

ARTICLE; BONE DEVELOPMENT; BONE PROSTHESIS; BONE REGENERATION; CELL CULTURE; CELL PROLIFERATION; DRUG EFFECT; HUMAN; IN VITRO STUDY; OSTEOBLAST; PHYSIOLOGY;

BONE REGENERATION; BONE SUBSTITUTES; CELL PROLIFERATION; CELLS, CULTURED; DENTAL ENAMEL PROTEINS; HUMANS; INDICATORS AND REAGENTS; OSTEOBLASTS; OSTEOGENESIS; OXAZINES; XANTHENES;

EID: 73249140966     PISSN: None     EISSN: 1746160X     Source Type: Journal    
DOI: 10.1186/1746-160X-5-23     Document Type: Article

References (36)

1. Allograft and alloplastic bone substitutes: a review of science and technology for the craniomaxillofacial surgeon. BL Eppley WS Pietrzak MW Blanton, J Craniofac Surg 2005 16 6 981 9 10.1097/01.scs.0000179662.38172.dd 16327544
2. The efficiancy of various bone augmentation procedures for dental implants: a Cochrane systematic review of randomized controlled clinical trials. M Esposito, et al. Int J Oral Maxillofac Implants 2006 21 5 696 710 17066630
3. Long-term clinical results on the use of bone-replacement grafts in the treatment of intrabony periodontal defects. Comparison of the use of autogenous bone graft plus calcium sulfate to autogenous bone graft covered with a bioabsorbable membrane. M Orsini, et al. J Peridontol 2008 79 9 1630 1637 10.1902/jop.2008.070282
4. Healing of human intrabony defects following regenerative periodontal therapy with a bovine-derived xenograft and guided tissue regeneration. A Sculean, et al. Clin Oral Investig 2004 8 2 70 74 10.1007/s00784-004-0254-7 14767696
5. Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects. A Sculean, et al. J Peridontol 2008 79 10 1991 1999 10.1902/jop.2008.080009
6. Pore characteristics of bone subsitute materials assessed by microcomputed tomography. MO Klein, et al. Clin Oral Implants Res 2009 20 67 74 10.1111/j.1600-0501.2008.01605.x 19126109
7. A thorough physicochemical characterisation of 14 calcium phosphate-based bone substitution materials in comparison to natural bone. D Tadic M Epple, Biomaterials 2004 25 6 987 94 10.1016/S0142-9612(03)00621-5 14615163
8. [Determining the size of the specific surface of bone substitutes with gas adsorption]. G Weibrich, et al. Mund Kiefer Gesichtschir 2000 4 3 148 52 10.1007/s100060050187 10900957
9. A review of bone substitutes. ST Kao DD Scott, Oral Maxillofac Surg Clin North Am 2007 19 4 513 21 10.1016/j.coms.2007.06.002 18088902
10. The ultrastructure and processing properties of Straumann Bone Ceramic and NanoBone. S Dietze, et al. Folia Morphol (Warsz) 2006 65 1 63 5 16783740
11. Biocompatibility studies of endothelial cells on a novel calcium phosphate/SiO2-xerogel composite for bone tissue engineering. BW Thimm, et al. Biomed Mater 2008 3 1 15007 10.1088/1748-6041/3/1/015007 18458494
12. Macroscopical, histological, and morphometric studies of porous bone-replacement materials in minipigs 8 months after implantation. KO Henkel, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006 102 5 606 13 10.1016/j.tripleo.2005.10.034 17052636
13. Growth and proliferation of human osteoblasts on different bone graft substitutes: an in vitro study. A Kübler, et al. Implant Dent 2004 13 2 171 179 15179094
14. Differential effects of bone graft substitutes on regeneration of bone marrow. Z Schwartz, et al. Clin Oral Implants Res 2008 19 12 1233 1245 10.1111/j.1600-0501.2008.01582.x 19040438
15. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration. A Sculean, et al. J Clin Periodontol 2008 35 9 817 24 10.1111/j.1600-051X.2008.01295.x 18647201
16. The application of an enamel matrix protein derivative (Emdogain) in regenerative periodontal therapy: a review. A Sculean, et al. Med Princ Pract 2007 16 3 167 80 10.1159/000100386 17409750
17. Clinical outcomes with bioactive agents alone or in combination with grafting or guided tissue regeneration. L Trombelli R Farina, J Clin Periodontol 2008 35 s8 117 135 10.1111/j.1600-051X.2008.01265.x
18. Biological mediators and periodontal regeneration: a review of enamel matrix proteins at the cellular and molecular levels. DD Bosshardt, J Clin Periodontol 2008 35 s8 87 105 10.1111/j.1600-051X.2008.01264.x
19. Hertwig's epithelial root sheath, enamel matrix proteins, and initiation of cementogenesis in porcine teeth. DD Bosshardt A Nanci, J Clin Periodontol 2004 31 8 184 192 10.1111/j.0303-6979.2004.00473.x 15016022
20. In vitro biologic response of human bone marrow stromal cells to enamel matrix derivative. L Guida, et al. J Periodontol 2007 78 2190 2196 10.1902/jop.2007.070185 17970687
21. Effect of enamel matrix protein derivative on the attachment, proliferation, and viability of human SaOs(2) osteoblasts on titanium implants. F Schwarz, et al. Clin Oral Investig 2004 8 3 165 71 10.1007/s00784-004-0259-2 15060819
22. Enhanced proliferation, attachment and osteopontin expression by porcine periodontal cells exposed to Emdogain. JC Rincon, et al. Arch Oral Biol 2005 50 1047 1054 10.1016/j.archoralbio.2005.04.006 16342405
23. In vitro assessment of motility and proliferation of human osteogenic cells on different isolated extracellular matrix components compared with enamel matrix derivative by continuous single-cell observation. MO Klein, et al. Clin Oral Implants Res 2007 18 1 40 5 10.1111/j.1600-0501.2006.01279.x 17224022
24. Porcine fetal enamel matrix derivative stimulates proliferation but not differentiation of pre-osteoblastic 2T9 cells, inhibits proliferation and stimulates differentiation of osteoblast-like MG63 cells, and increases proliferation and differentiation of normal human osteoblast NHOst cells. Z Schwartz, et al. J Periodontol 2000 71 1287 1296 10.1902/jop.2000.71.8.1287 10972644
25. Emdogain promotes osteoblast proliferation and differentiation and stimulates osteoprotegerin expression. J He, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004 97 2 239 45 10.1016/j.tripleo.2003.10.005 14970783
26. Clinical evaluation of an enamel matrix protein derivative (Emdogain) combined with a bovine-derived xenograft (Bio-Oss) for the treatment of intrabony periodontal defects in humans. A Sculean, et al. Int J Periodontics Restorative Dent 2002 22 3 259 67 12186348
27. Osteoprogenitor cell differentiation to mature bone-forming osteoblasts. JE Aubin JM Heersche, Drug Development Research 2000 49 3 206 215 10.1002/(SICI)1098-2299(200003)49:3<206::AID-DDR11>3.0.CO;2-G
28. A new, simple, nonradioactive, nontoxic in vitro assay to monitor corneal endothelial cell viability. EM Larson, et al. Invest Ophthalmol Vis Sci 1997 38 10 1929 33 9331256
29. Osteoinduction, osteoconduction and osseointegration. TJC Albrektsson, Eur Spine J 2001 10 96 101
30. Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. E Tsuruga, et al. J Biochem 1997 121 2 317 24 9089406
31. Porosity of 3D biomaterial scaffolds and osteogenesis. V Karageorgiou D Kaplan, Biomaterials 2005 26 27 5474 91 10.1016/j.biomaterials.2005.02.002 15860204
32. Promotion of bone formation using highly pure porous beta-TCP combined with bone marrow-derived osteoprogenitor cells. J Dong, et al. Biomaterials 2002 23 23 4493 502 10.1016/S0142-9612(02)00193-X 12322969
33. Nanostructured biomaterials for tissue engineering bone. TJ Webster ES Ahn, Adv Biochem Eng Biotechnol 2007 103 275 308 17195467
34. Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation In vitro: implications and applications for bone tissue engineering. ID Xynos, et al. Calcif Tissue Int 2000 67 4 321 9 10.1007/s002230001134 11000347
35. A histologic and histomorphometric evaluation of anorganic bovine bone retrieved 9 years after a sinus augmentation procedure. T Traini, et al. J Periodontol 2007 78 5 955 61 10.1902/jop.2007.060308 17470032
36. Human periodontal fibroblast response to a nanostructured hydroxyapatite bone replacement graft in vitro. A Kasaj, et al. Arch Oral Biol 2008 53 7 683 9 10.1016/j.archoralbio.2008.01.009 18325481